Carlsmed
Carlsmed (Nasdaq: CARL) is a Carlsbad, California medical technology company that builds personalized spine surgery. Its aprevo technology platform combines AI-enabled segmentation of a patient's own imaging with prior-outcomes data to produce a personalized surgical plan and patient-specific interbody fusion devices, manufactured on a digital production line and delivered to hospitals in under ten days. The platform is FDA-cleared for lumbar and cervical indications, holds FDA Breakthrough Device Designation, and earned CMS New Technology Add-On Payment status for cervical fusion in 2025. Surgeons review, approve and track plans through the myaprevo iOS application. Carlsmed operates under ISO 13485 and MDSAP certification and completed its IPO in July 2025. It publishes no public developer program, API documentation, or machine-readable API contract.
Carlsmed is profiled on the APIs.io network. Tagged areas include Company, Health Care, Medical Devices, Surgery, and Spine.
Carlsmed’s developer surface includes engineering blog, support, and 11 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API
Other 3
Properties that don't map to a standard resource type